Palmoplantar pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Palmoplantar pustulosis est dermatitis pustulosa recidivans longa (id est pustulosis vel pustularis psorias) in palmis et plantis tantum locata, histologice intraepidermalibus pusillis neutrophillis repleta. Usus retinoidorum systemicorum solus, et in compositione cum photochemotherapia, ad melioranda symptomata palmoplantar pustulosis.

○ Curatio
Acitretinum orale efficax est pro hoc genere psoriasis.
#Acitretin
☆ AI Dermatology — Free Service
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
  • In hoc casu etiam pompholyx suspicari potest.
  • In absentia pustularum, manus scabie etiam considerari potest ut diagnosis differentialis.
References Palmoplantar Psoriasis 28846363 
NIH
Palmoplantar psoriasis est genus psoriasis quod maxime cutem in palmis et plantis afficit. Cutis densata manifestatur vel sicca, vel pustulosa, vel mixtura utriusque speciei.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).